Global Atropine Market Size To Worth USD 279.99 Million by 2033 | CAGR of 2.39%
Category: HealthcareGlobal Atropine Market Worth USD 279.99 Million by 2033
According to a research report published by Spherical Insights & Consulting, the Global Atropine Market Size is Expected to Grow from USD 221.11 Million in 2023 to USD 279.99 Million by 2033, at a CAGR of 2.39% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 260 pages with 128 Market data tables and figures & charts from the report on the "Global Atropine Market Size, Share, and COVID-19 Impact Analysis, By Formulation (Injectables, Oral, and Ophthalmic), By Indication (Gastroenterology, Poisoning Treatment, Respiratory Medicine, Ophthalmology, Cardiology, Anesthesia, and Others), By End-User (Clinics, Hospitals, Ambulatory Surgical Centers, and Retail Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/atropine-market
The atropine market involves the development, production, and sale of atropine, a pharmaceutical compound used in various therapeutic applications. The increasing incidence of myopia and bradycardia is driving demand for atropine, with myopine being the most commonly marketed product. The FDA and DOD have collaborated on safety and efficacy requirements, leading to increased demand for atropine. The market is projected to exceed USD 279.99 million by 2033 due to these factors. the atropine market is expanding owing to its role in cardiac procedures and ophthalmology, particularly in treating eye disorders, particularly among the aging population, and its application in cardiac stress tests and surgeries. The growing need for surgical procedures and medical emergencies supports atropine's consistent market demand, which is further enhanced by its ability to effectively manage patients. However, adverse effects and contraindications derived from atropine usage may restrict the market growth.
The injectable segment held the greatest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the formulations, the global atropine market is categorized as injectables, oral, and ophthalmic. Among these, the injectable segment held the greatest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. This is attributed to its rapid therapeutic effect, 100% bioavailability, sustained delivery, uniform absorption, precise dosing, and effectiveness in emergencies.
The ophthalmology segment accounted to grow at the highest pace in 2023.
Based on the indications, the global atropine market is categorized as gastroenterology, poisoning treatment, respiratory medicine, ophthalmology, cardiology, anesthesia, and others. Among these, the ophthalmology segment accounted to grow at the highest pace in 2023. The ophthalmology segment dominates the market due to ongoing clinical trials, research, and the increasing prevalence of eye disorders like myopia and atropine in diagnostic procedures.
The hospitals segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the end-user, the global atropine market is categorized as clinics, hospitals, ambulatory surgical centers, and retail pharmacies. Among these, the hospitals segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. The segment's expansion is attributed to the availability of advanced services, individualized care, regular doctor visits, and intensive care unit (ICU) facilities for patients requiring immediate attention.
North America is expected to hold the greatest share of the global atropine market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global atropine market over the forecast period. North America's atropine market is dominated by advanced healthcare infrastructure, research investment, robust regulatory framework, chronic diseases, aging populations, leading pharmaceutical companies, and public awareness.
Asia Pacific is predicted to hold the fastest-growing region of the global atropine market throughout the estimated period. This is ascribed to healthcare sector expansion, increased investments, and high demand for improved services, bolstered by technological advancements.
Major key players in the global atropine market are Abbott Laboratories, Syndnexis, Amegen Inc., Bayer AG, Zoetis Inc., Bristol Myers Squibb Company, Eli Lilly and Company, AdvaCare Pharma, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In February 2024, Santen Pharmaceutical Co Ltd. announced that it had applied for manufacturing and marketing approval in Japan for the product STN1012700/DE-127 (generic name: atropine sulfate hydrate ophthalmic solution. DE-127 is an eyedrop treatment developed by Santen and the Singapore Eye Research Institute to slow myopia progression, containing 0.025% atropine sulfate hydrate.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global atropine market based on the below-mentioned segments:
Global Atropine Market, By Formulation
- Injectables
- Oral
- Ophthalmic
Global Atropine Market, By Indication
- Gastroenterology
- Poisoning treatment
- Respiratory Medicine
- Ophthalmology
- Cardiology
- Anesthesia
- Others
Global Atropine Market, By End-User
- Clinics
- Hospitals
- Ambulatory Surgical Centers
- Retail Pharmacies
Global Atropine Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?